Predicting Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease in a Multicenter Observational Cohort and CONQUER
CONQUER Registry to Track Disease Progression in Systemic Sclerosis (Scleroderma)
Sponsor: Scleroderma Research Foundation
Enrolling: Male and Female Patients
IRB Number: AAAR6143
Contact: Elana Bernstein, MD: 212-305-4308 / ejb2153@cumc.columbia.edu
Additional Study Information: The purpose of this study is to develop a cohort of patients with early scleroderma and to collect data on clinical outcomes, radiological tests, laboratory tests, and to obtain biological specimens for testing.
Investigator
Elana Bernstein, MD
Do You Qualify?
Are you at least 18 years old? Yes No
Have you been diagnosed with systemic sclerosis (scleroderma)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Elana Bernstein, MD
ejb2153@cumc.columbia.edu
212-305-4308
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE